• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Markets Equities Company Results

COVID-19 boosts Fidson Healthcare Plc’s Q2 2020 performance

Adeyemi Adebayo by Adeyemi Adebayo
September 22, 2020
in Company Results
Fidson Healthcare Plc,Fidson Healthcare Plc records 30.28% increase in 2020 9M revenues.
Share on FacebookShare on TwitterShare on Linkedin

Fidson Healthcare Plc’s reported revenue for Q2 2020, increased year on year by 16.19%, from N3.83 billion to N4.45 billion.

Fidson Healthcare Plc is one of the leading pharmaceutical manufacturing companies in Nigeria. It is the second-largest pharmaceutical company in the country by Q2 2020 revenue, after GlaxoSmithKline Consumer Nigeria Plc – with a revenue of N5.44 billion.

Explore the Nairametrics Research Website for Economic and Financial Data

RelatedStories

Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020

Fidson Healthcare records N4.8 billion profit in Q1 as revenue spikes across key segments 

May 3, 2025
Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020

Fidson Healthcare soars 24% in early February 2025, breaks N19 mark

February 10, 2025

A cursory analysis of the company’s result shows revenues got a boost, despite the challenges of Covid-19. The lockdown affected the importation of products including some of its exports.  Yet revenue topped, thanks to an increase in sales of prescription drugs.   

Fidson has two key segments – Prescription (Ethical) drugs, and Over the counter sales. While revenues from over the counter sales were flat; the company booked revenues of N4.69 billion, compared with N3.7 billion in the period under review.  COVID-19 pandemic has largely boosted sales for most healthcare companies, as Nigerians rushed to buy immune boosters, thought to provide protection against the virus.  

READ: Japan’s Ohara Pharmaceutical takes over 20% stake in Fidson Healthcare

Prescription drugs (Ethical drugs), also increased as a result of that, when compared with Q2 2019. The COVID-19 pandemic boosted the revenue of pharmaceutical companies, compared with previous periods as medicine sales surged.   

Apart from growing demand, the sector has also attracted interest from the CBN and the FG. Recently, The Central Bank of Nigeria (CBN), intervened in the sector through the provision of N100 billion credit, towards managing the pandemic, “providing opportunities to explore the development of new products,” according to the Chairman of the company, Mr. Segun Adebanji.  

READ: Nigeria’s total foreign trade drops to N6.24 trillion in Q2 2020, export plunges by 52%

Despite the interventions, the sector still faces a major challenge, as noted by the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN). The association said that local drug manufacturers may run out of business, as most raw materials and nearly finished pharmaceutical products are imported into the country. The Association submits that the reason for this is inconsistent government policies, which results in a lack of investment in the sector.    

Commenting on the surge in profits and reduction in certain costs, the Chairman of the company noted that various cost-cutting strategies were utilized in driving performance upward. The Earnings Per Share (EPS) of the company, grew by 433.33% from -6 kobo at the end of 2018, to 20 kobo at the end of 2019.   

READ: Fidson reports over 500% increase in profit for 2019

Fidson shares currently trade at N3.50 per unit. The share’s highest price in 52 weeks was N4.05 and the lowest was N2.21. A total volume of 1,132,011 units was sold in the last seven days trades. Shares outstanding is 2,086,360,250 units. As for GSK, a total volume of 2,882,893 units, was sold in the last seven days trades. Shares outstanding is 1,195,876,488 units.   


Follow us for Breaking News and Market Intelligence.
Tags: Business NewsCompany Financial ResultsCOMPANY RESULTSFidson Healthcare PlcFidson Healthcare Plc - Financials
Adeyemi Adebayo

Adeyemi Adebayo

Adeyemi holds a PhD in Accounting Sciences. He has worked in the Educational Sector and as an Independent Consultant.

Related Posts

Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020
Company Results

Fidson Healthcare records N4.8 billion profit in Q1 as revenue spikes across key segments 

May 3, 2025
Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020
Equities

Fidson Healthcare soars 24% in early February 2025, breaks N19 mark

February 10, 2025
Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020
Corporate Updates

Fidson Healthcare Plc appoints three new Directors

February 6, 2025
Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020
Dividends

Fidson hits Low, Slips 21% year-to-date in August 

August 26, 2024
Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020
Company News

Fidson Healthcare seeks to raise N20 billion capital through share offering  

July 8, 2024
Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020
Company Results

Fidson Healthcare posts N5.9 billion pre-tax profit in 2023 with ethical drugs as major revenue source 

April 4, 2024
Next Post
Income of Nigerian households decline in Agriculture, and 2 others - NBS Survey, How Nigeria’s GDP growth and food security hinges on financial inclusion of farmers

Are we heading towards a food crisis?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Emple
nlng
first bank








DUNS

Recent News

  • Toyin Abraham’s Iyalode nears N300 million at Nigeria box office 
  • GTCO CEO Segun Agbaje: Banks had ample notice on forbearance loans – CBN’s action no surprise
  • Hollywood’s “Jurassic World: Rebirth” debuts N52.5 million in Nigerian cinemas

Follow us on social media:

Recent News

Toyin Abraham’s Iyalode nears N300 million at Nigeria box office 

Toyin Abraham’s Iyalode nears N300 million at Nigeria box office 

July 12, 2025
Top 5 highest paid bank CEOs of 2022 

GTCO CEO Segun Agbaje: Banks had ample notice on forbearance loans – CBN’s action no surprise

July 12, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics